Hemophilia Federation of America is pleased to offer Dateline LIVE: Navigating Approved Products and Emerging Therapies.
Annually, we compile a comprehensive list of therapies approved by the Food and Drug Administration as well as all investigational therapeutic products undergoing clinical trial and have published that list in a special issue of our quarterly magazine Dateline Federation. Now, we are bringing this special issue to life.Â
Wednesday, June 23 | 4 p.m. – 8:15 p.m. ET
- Welcome by Sharon Meyers
- Product Informational Session by Genentech, CSL Behring, Sanofi Genzyme
- Break
- Shared Decision Making: Making the Most of the Patient/Provider Relationship
- Rap Session
Watch Day 1
Thursday, June 24 | 4 p.m. – 8:15 p.m. ET
- Bleeding Disorders Alphabet Soup: What Do These Mean
- Product Informational Session by HEMA Biologics and Sanofi Genzyme
- Break
- What to Expect When Participating in Clinical Trials
- Rap Session
Watch Day 2
Friday, June 25 | 4 p.m. – 6:45 p.m. ET
- Get Counted: The Importance of Registries
- Emerging Therapies: The Latest in Clinical Trials
- Final Word by Sonji Wilkes
Watch Day 3
Sponsored Digital Resources
Below, you’ll find resources provided from our Dateline Live sponsors. Don’t miss their product information sessions taking place during the event and be sure to download their resources to learn all about their offerings.
CSL Behring:Â Reach Higher With the Long-Lasting Protection of AFSTYLAÂ View PDF | Download PDF
CSL Behring: Long Lasting Bleed Protection for the Warrior Within View PDF | Download PDF
Genentech: Hemlibra Key Considerations View PDF | Download PDF
Genentech: How Hemlibra Works View PDF | Download PDF
HEMA Biologics: Introducing SEVENFACTÂ View PDF | Download PDF
Sanofi Genzyme: ALPROLIX® Quick Guide View PDF | Download PDF
Sanofi Genzyme: ELOCTATE® Quick Guide View PDF | Download PDF
Spark Therapeutics: Meet the Spark Therapeutics Patient Advocacy Team View PDF | Download PDF
Thank you to our Sponsors
